We are live on ! Find out more
FFVM

Founders Fund VII Management Portfolio holdings

AUM $2.03M
1-Year Est. Return 72.34%
This Fund
S&P 500
This Quarter Est. Return
-6.67%
1 Year Est. Return
+72.34%
3 Year Est. Return
-64.66%
5 Year Est. Return
-90.66%
10 Year Est. Return
AUM
$40.3M
AUM Growth
-$2.89M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABCL icon
1
AbCellera Biologics
ABCL
$3.99B
$37.3M 92.58%
3,773,530
CMPS
2
Compass Pathways
CMPS
$2.04B
$2.99M 7.42%
278,880

Similar funds

Founders Fund VII Management's Q3 2022 Portfolio in Review

As of Q3 2022, Founders Fund VII Management held 2 positions worth $40.3M, down 6.7% from $43.2M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2022: portfolio turnover was 0%. Founders Fund VII Management opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Founders Fund VII Management's ten largest holdings make up 100% of its $40.3M portfolio in Q3 2022.
  • Founders Fund VII Management opened 0 new positions and closed 0 in Q3 2022.
  • Founders Fund VII Management's portfolio value fell 6.7% quarter-over-quarter to $40.3M.

Based on Founders Fund VII Management's 13F filing for Q3 2022, filed 14 Nov 2022.